Orchid Chemicals Fact Sheet, Orchid Chemicals Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Fact Sheet    (ORCHID)


Know More: Is India's Economic Recovery Sustainable?


Here is the latest financial fact sheet of Orchid Chemicals. For more details, see the Orchid Chemicals quarterly results and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

ORCHID PHARMA Price History

Price Rs 5.3
Mkt Cap Rs m 448
Vol '000 46.3
P/E X -0.4
P/CF X -0.1
EPS (TTM) Rs -12.8
% ch % -4.9
No. of shares m 85.26
% ch week % -22.3
% ch 1-mth % 17.7
% ch 12-mth % -24.7
52 week H/L Rs 8.6/3.0
(As on Jul 24, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ORCHID PHARMA Financials

No. of Mths
Year Ending
12
Mar-09
*
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
18
Sep-13
*
5-Yr Chart
Click to enlarge
ORCHID PHARMA EQUITY SHARE DATA
High Rs330239344325194 
Low Rs577512811235 
Sales per share (Unadj.) Rs184.1190.7253.0266.0276.5 
Earnings per share (Unadj.) Rs-7.048.222.213.8-79.2 
Diluted earnings per shareRs-5.739.818.311.4-65.5 
Cash flow per share (Unadj.) Rs12.170.241.135.7-43.5 
Dividends per share (Unadj.) Rs1.0010.003.003.000 
Adj. dividends per shareRs0.838.262.482.480.00 
Dividend yield (eoy) %0.56.41.31.40 
Book value per share (Unadj.) Rs90.0133.1151.8160.753.9 
Adj. book value per shareRs74.3110.0125.4132.844.6 
Shares outstanding (eoy) m70.4470.4470.4470.4470.45 
Bonus/Rights/Conversions  WC---ESOP 
Price / Sales ratio x1.10.80.90.80.4 
Avg P/E ratio x-27.83.310.615.8-1.4 
P/CF ratio (eoy) x16.02.25.76.1-2.6 
Price / Book Value ratio x2.21.21.61.42.1 
Dividend payout %-14.420.813.521.70 
Avg Mkt Cap Rs m13,63011,05916,62415,3918,067 
No. of employees `0004.03.7NA4.52.8 
Total wages/salary Rs m1,4091,7751,7371,7642,527 
Avg. sales/employee Rs Th3,210.03,630.9NM4,205.66,956.1 
Avg. wages/employee Rs Th348.7479.8NM396.0902.5 
Avg. net profit/employee Rs Th-121.3916.9NM218.8-1,993.0 
ORCHID PHARMA INCOME DATA
Net Sales Rs m12,96913,43517,81818,73619,477 
Other income Rs m86186447562407 
Total revenues Rs m13,82913,52018,26519,29819,884 
Gross profit Rs m1,706-1,5693,5643,5661,103 
Depreciation Rs m1,3401,5491,3351,5372,519 
Interest Rs m1,5652,4231,1681,7985,227 
Profit before tax Rs m-338-5,4551,509793-6,236 
Minority Interest Rs m000020 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m010,153207-39511 
Tax Rs m1521,306154-220-125 
Profit after tax Rs m-4903,3931,562975-5,580 
Gross profit margin %13.2-11.720.019.05.7 
Effective tax rate %-44.9-23.910.2-27.82.0 
Net profit margin %-3.825.38.85.2-28.7 
ORCHID PHARMA BALANCE SHEET DATA
Current assets Rs m15,95417,00515,26312,53311,014 
Current liabilities Rs m8,55810,85219,89415,51132,060 
Net working cap to sales %57.045.8-26.0-15.9-108.1 
Current ratio x1.91.60.80.80.3 
Inventory Days Days21611512713095 
Debtors Days Days1892001052234 
Net fixed assets Rs m25,54220,72220,74124,26129,440 
Share capital Rs m704704704704705 
"Free" reserves Rs m5,4798,4548,1069,3102,043 
Net worth Rs m6,3389,37710,69211,3233,800 
Long term debt Rs m26,15915,3036,04110,7429,018 
Total assets Rs m43,91639,90639,10239,38146,510 
Interest coverage x0.8-1.32.31.4-0.2 
Debt to equity ratio x4.11.60.60.92.4 
Sales to assets ratio x0.30.30.50.50.4 
Return on assets %2.414.67.07.0-0.8 
Return on equity %-7.736.214.68.6-146.9 
Return on capital %3.828.917.211.6-3.7 
Exports to sales %71.972.740.745.237.9 
Imports to sales %32.728.232.437.822.6 
Exports (fob) Rs m9,3209,7627,2598,4677,378 
Imports (cif) Rs m4,2343,7875,7737,0894,406 
Fx inflow Rs m9,59210,0527,8688,9287,513 
Fx outflow Rs m5,0065,2676,6588,2195,649 
Net fx Rs m4,5864,7851,2107091,865 
ORCHID PHARMA CASH FLOW
From Operations Rs m 459 -343 3,321 7,370 1,682 
From Investments Rs m -4,770 14,128 -3,674 -2,931 -9,860 
From Financial Activity Rs m 4,311 -10,768 -778 -4,802 6,644 
Net Cashflow Rs m 0 3,016 -1,130 -362 -1,535 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 32.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 4.6%
FIIs 3.3%
ADR/GDR 4.6%
Free float 55.3%
Shareholders 84,811
Pledged promoter(s) holding 54.9%
 

Company Information

REGD OFF Orchid Towers, 313, Valluvar Kottam Road, Nungambakkam, Chennai-34
E-MAIL corporate@orchidpharma.com WEB www.orchidpharma.com
TELEPHONE (044) 2821 1000 FAX (044) 2827 5960
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Integrated Enterp., II Flr., Kences Tower, North Usman Rd., Chennai-17
AUDITOR SNB Associates
CHM: K. Raghavendra Rao (MD) COMP SEC: L. Chandrasekar YEAR OF INC: 1992 BSE CODE: 524372 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   WYETH  TORRENT PHARMA  NOVARTIS  ALEMBIC PHARMA  SUVEN LIFESCIENCES  

Compare ORCHID PHARMA With:   WYETH  TORRENT PHARMA  NOVARTIS  ALEMBIC PHARMA  SUVEN LIFESCIENCES  

Compare ORCHID PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 377 Points Higher; Banking and Finance Stocks Rally(Closing)

After opening the day on a flat note, share markets in India extended gains as the session progressed and ended on a strong note, lifted by gains in financials and FMCG stocks.

Views on news

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now Views On News (Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

The Biggest Wealth Creating Opportunity that No One is Talking About (Profit Hunter)

Oct 14, 2020

The defence sector has gone under the radar despite positive developments. Here's why this sector can't be ignored for long...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA - TEVA PHARMA COMPARISON

COMPARE ORCHID PHARMA WITH

MARKET STATS